The House Committee on Public Health
76th Legislature
February 29, 2000
10:00 a.m. or upon adjournment
Capitol Extension
Pursuant to a notice posted on February 15, 2000, the House
Committee on Public Health met in a public hearing and was
called to order by the chair, Representative Gray, at 10:00 a.m.
The roll was answered as follows:
Present: Representatives Gray; Coleman; Glaze; Maxey;
McClendon; Uresti (6).
Absent: Representatives Capelo; Delisi; Hilderbran (3).
A quorum was present.
The chair made opening remarks and announced that the purpose of
the meting was to address the role and potential of disease
management in Texas' public health programs that serve
chronically ill populations, as charged by Speaker Laney.
The chair thanked Reps. McClendon and Uresti for their
leadership on this charge, and announced that Rep. McClendon
would chair the remainder of the meeting.
(Representative McClendon in chair.)
The chair called upon witnesses who were invited to give the
committee an overview of disease management.
The following persons provided oral testimony:
Reyn Archer, M.D., Commissioner, Texas Department of Health
Karen Hale, Commissioner, Texas Department of Mental Health
and Mental Retardation
Beverly L. Koops, MD, Medical Director, Health Care
Financing, Texas Department of Health
The chair called upon witnesses who were invited to give the
committee an overview of disease management initiatives in
Virginia and Florida.
The following persons provided oral and written testimony:
Louis Rossiter, PhD, Director, Healthcare Policy , The
Virginia
Health
Outcomes
Partnersh
ip
Ruben J. King-Shaw, Executive Director, Agency for
Health Care Administration, Florida
The chair called upon witnesses who were invited to give the
committee an overview of various perspectives of disease
management.
The following persons provided oral and written testimony:
Michael Speer MD, Chair, Council on Scientific Affairs,
Texas Medical Association
Rosette Davila, R.Ph., Member, Texas Pharmacy Association
Ron Lindsay, Health Policy, Finance, Record Management
Technology
John P. Drobnica, PA-C, Member, Texas Academy of Physician
Assistants
Clair B. Jordan, Executive Director, Texas Nurses
Association
James Jacobson, General Counsel, Disease Management
Association of America
The chair called upon witnesses who were invited to give the
committee an overview of private disease management initiatives.
The following persons provided oral and written testimony:
Allan J. Chernov MD, Regional Medical Director, Aetna US
HealthCare
Sheila Beckett, Executive Director, Employee Retirement
System
The chair called upon the witness who was invited to brief the
committee regarding possibilities within Texas' Medicaid
population.
The following person provided oral testimony:
Don Gilbert, Commissioner, Health and Human Services
Commission
The committee considered public testimony.
(Representative Gray in chair.)
At 4:00p.m., upon the motion of the chair and without objection,
the meeting was adjourned subject to the call of the chair.
________________________
Rep. Patricia Gray, Chair
________________________
Pam Crowley, Chief Clerk